Clinical Trial Update: To Estimate Relative Bioavailability of 5 Formulations of Ronacaleret Given to Healthy Postmenopausal Females [Phase 1]

View source ↗

Summary

A Phase 1 study comparing five formulations of ronacaleret to assess relative bioavailability in healthy postmenopausal women with osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Ronacaleret (ronacaleret)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED